Weight loss drug shows promise in clinical trial
Links shared publicly online about this topic.
- 853total visits
Weight loss drug shows promise in clinical trial
View full resource at asiaone.com
Tags: Weight Loss, Drug, Clinical Trial
Most Recently Shared on September 23, 2010 at 5:56 am By:
Weight loss drug shows promise in clinical trial: LOS ANGELES (Reuters) - An experimental weight loss drug helped ... http://bit.ly/9n2stO
Drug Shows Promise in Fighting Obesity - WSJ.com
online.wsj.com — “A drug that kills a type of fat cell by choking off its blood supply caused significant weight loss in obese monkeys, potentially setting the stage for a new pharmaceutical approach to attacking obesity, according to a study.” View full resource at online.wsj.com
Most Recently Shared on November 9, 2011 at 8:05 pm By:
Raymond DuBois Doctor, Internist, Gastroenterologist, Health Executive, and Physician
Drug Slims Down Obese Monkeys by Killing Fat Cells: http://t.co/ht57km36 via @WSJ
A Powerful New Cystic Fibrosis Drug Shows Promise – TIME Healthland
healthland.time.com — “For the first time, cystic fibrosis patients may have a drug that treats the underlying cause of their disease rather than just its symptoms. According to a new clinical trial, the experimental drug helped patients breathe easier, gain healthy weight and cut infections.” View full resource at healthland.time.com
Most Recently Shared on November 4, 2011 at 6:05 pm By:
Cystic fibrosis drug shows promise | http://t.co/iQOrXwGx
Diabetes Prevention Program - National Diabetes Information Clearinghouse
diabetes.niddk.nih.gov — “Summarizes the findings of the Diabetes Prevention Program, a major clinical trial that, over the 3 years of the study, showed diet and exercise sharply reduced the chances a person with impaired glucose tolerance will develop diabetes. Lists the risk factors for type 2 diabetes.” View full resource at diabetes.niddk.nih.gov
Most Recently Shared on July 28, 2011 at 8:53 pm By:
Study: Weight-loss combo pill shows promise – The Chart - CNN.com Blogs
thechart.blogs.cnn.com — “Two existing drugs, in combination, have shown significant promise in promoting weight loss, according to a new report. The drugs, phentermine and Topamax, in combination with lifestyle and weight-loss counseling were associated with a 18-22 pound weight loss in trial participants, compared wit...” View full resource at thechart.blogs.cnn.com
Most Recently Shared on April 11, 2011 at 8:44 am By:
Global Healing Ctr. Health Business
Study: Weight-loss combo pill shows promise http://bit.ly/fRRPWQ via: @sanjayguptaCNN
New Two Drug Combination For Obesity Compares Favourably With Currently Approved And Emerging Weight-Loss Drugs - QualityPoint Technologies
qualitypointtech.net — “A new two drug combination (phentermine and topiramate) achieves more than double the weight loss of orlistat, the only drug approved for the long-term treatment of obesity, and compares favourably with drugs in clinical development reported in phase 3 trials*. The findings published Online First in The Lancet also suggest that this promising new treatment has additional metabolic benefits - improving blood pressure, lipids, glycaemia, and inflammatory markers. Obesity is associated with reduced” View full resource at qualitypointtech.net
Most Recently Shared on April 11, 2011 at 7:35 am By:
New Two Drug Combination For Obesity Compares Favourably With Currently Approved And Emerging Weight-Loss Drugs: A... http://bit.ly/ikBjqu
FDA rejects weight loss drug Contrave - The Boston Globe
boston.com — “For the third time in less than a year, the Food and Drug Administration has rejected a drug promising to melt the fat away. The agency said yesterday it wouldn’t consider approving the diet drug, Contrave, until its manufacturer conducts a clinical trial to further assess its heart risks.” View full resource at boston.com
Most Recently Shared on February 2, 2011 at 8:58 am By:
Suzanne Trupin Physician, Doctor, ObGyn Physician, and Surgeon
FDA rejects weight loss drug Contrave - The Boston Globe: http://bit.ly/i8NpJk so still looking for alternatives for the patients.
Zafgen Weight Loss Drug Shows Promise in First Human Test | Xconomy
xconomy.com — “People working on new drugs for obesity had a pretty crummy 2010 on the whole, but now an intriguing startup in Cambridge, MA, called Zafgen is starting the new” View full resource at xconomy.com
Most Recently Shared on January 5, 2011 at 2:15 pm By:
Luke Timmerman Health Communicator
After a lousy 2010 for obesity drugs, Cambridge, MA-based Zafgen shows promise in 1st trial result of 2011. http://bit.ly/gtssDJ
Lorcaserin Phase 3 Clinical Trial in Patients with Type 2 Diabetes Shows Statistically Significant Weight Loss - Drugs.com MedNews
drugs.com — “Arena Conference Call and Webcast Scheduled for Today at 8 30 SAN DIEGO and WOODCLIFF LAKE, N.J., Nov. 9, 2010 Arena Pharmaceuticals, Inc. (Nasdaq ARNA) and Eis” View full resource at drugs.com
Most Recently Shared on November 9, 2010 at 3:21 pm By:
Drugs and Devices OW OW Health
Lorcaserin Phase 3 Clinical Trial in Patients with Type 2 Diabetes Shows Statistically Significant Weight ... http://bit.ly/czZKGP #drug
FDA Yanks Meridia — And Finds It In A Supplement - Matthew Herper - The Medicine Show - Forbes
blogs.forbes.com — “After years of controversy, the Food and Drug Administration has asked Abbott Laboratories to yank the weight loss drug Meridia, generically known as sibutramine, from the market as a result of a large clinical trial that found the drug increased the rate of heart attack and stroke in patients at [...]” View full resource at blogs.forbes.com
Most Recently Shared on October 8, 2010 at 5:28 pm By:
Drugs and Devices OW OW Health
FDA Yanks Meridia ? And Finds It In A Supplement: After years of controversy, the Food and Drug Administratio... http://bit.ly/czHbAP #drug
Weight loss drug pulled from market – The Chart - CNN.com Blogs
pagingdrgupta.blogs.cnn.com — “Abbott Laboratories has agreed to take its obesity drug Meridia (sibutramine) off the market, the U.S. Food and Drug Administration announced Friday. The company voluntarily withdrew the drug because clinical trial studies showed there was an increased risk of heart attacks and strokes in people ...” View full resource at pagingdrgupta.blogs.cnn.com
Most Recently Shared on October 8, 2010 at 4:41 pm By:
James Beckerman, MD Physician, Doctor, Internist, and Cardiologist
Glad I was able to add this important information before we go to publication! http://bit.ly/d1vJMZ #sibutramine
Medical News: ENDO: Drug Combo Boosts Weight Loss and Quality of Life - in Meeting Coverage, ENDO from MedPage Today
medpagetoday.com — “WASHINGTON -- Obese patients lost almost 10% of their body weight when treated with a fixed-dose combination of two generic drugs and intensive behavior modification, a randomized trial showed.” View full resource at medpagetoday.com
Most Recently Shared on June 19, 2009 at 6:23 pm By:
Combination therapy with an anti-depressant and anti-alcohol dependence drug might help women lose weight. http://tinyurl.com/nv8a9p
Advertisement
